UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systematic review: hypomagnesaemia induced by proton pump inhibition

Alimentary pharmacology & therapeutics, 2012-09, Vol.36 (5), p.405-413

2012

Volltextzugriff (PDF)

On-demand anakinra treatment is effective in mevalonate kinase deficiency

Annals of the rheumatic diseases, 2011-12, Vol.70 (12), p.2155-2158

2011

Volltextzugriff (PDF)

A Risk Assessment of Factors for the Presence of Angiodysplasias During Endoscopy and Factors Contributing to Symptomatic Bleeding and Rebleeds

Digestive diseases and sciences, 2019-10, Vol.64 (10), p.2923-2932

2019

Volltextzugriff (PDF)

Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation

Surgical endoscopy, 2020-01, Vol.34 (1), p.209-215

2020

Volltextzugriff (PDF)

The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes

Alimentary pharmacology & therapeutics, 2011-08, Vol.34 (3), p.335-343

2011

Volltextzugriff (PDF)

NaV1.7 Gain-of-Function Mutations as a Continuum: A1632E Displays Physiological Changes Associated with Erythromelalgia and Paroxysmal Extreme Pain Disorder Mutations and Produces Symptoms of Both Disorders

The Journal of neuroscience, 2008-10, Vol.28 (43), p.11079-11088

2008

Volltextzugriff (PDF)

Genetics and mechanisms of hepatic cystogenesis

Biochimica et biophysica acta. Molecular basis of disease, 2018-04, Vol.1864 (4), p.1491-1497

2018

Volltextzugriff (PDF)

Antiviral therapy in chronic hepatitis E: a systematic review

Journal of viral hepatitis, 2015-12, Vol.22 (12), p.965-973

2015

Volltextzugriff (PDF)

The long-term outcome of patients with polycystic liver disease treated with lanreotide

Alimentary pharmacology & therapeutics, 2012-01, Vol.35 (2), p.266-274

2012

Volltextzugriff (PDF)

Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD study

BMC gastroenterology, 2022-02, Vol.22 (1), p.82-82, Article 82

2022

Volltextzugriff (PDF)

Prospective multicentre cohort study of patient-reported outcomes after cholecystectomy for uncomplicated symptomatic cholecystolithiasis

British journal of surgery, 2015-10, Vol.102 (11), p.1402-1409

2015

Volltextzugriff (PDF)

Decreased tacrolimus plasma concentrations during HCV therapy: a drug–drug interaction or is there an alternative explanation?

International journal of antimicrobial agents, 2017-03, Vol.49 (3), p.379-382

2017

Volltextzugriff (PDF)

Nav1.7-related small fiber neuropathy: impaired slow-inactivation and DRG neuron hyperexcitability

Neurology, 2012-05, Vol.78 (21), p.1635

2012

Volltextzugriff (PDF)

Somatostatin analogues improve health‐related quality of life in polycystic liver disease: a pooled analysis of two randomised, placebo‐controlled trials

Alimentary pharmacology & therapeutics, 2015-09, Vol.42 (5), p.591-598

2015

Volltextzugriff (PDF)

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Clinical pharmacokinetics, 2016-12, Vol.55 (12), p.1471-1494

2016

Volltextzugriff (PDF)

Safety and efficacy of different lanreotide doses in the treatment of polycystic liver disease: pooled analysis of individual patient data

Alimentary pharmacology & therapeutics, 2013-08, Vol.38 (4), p.397-406

2013

Volltextzugriff (PDF)

Systematic review: the management of hepatic cyst infection

Alimentary pharmacology & therapeutics, 2015-02, Vol.41 (3), p.253-261

2015

Volltextzugriff (PDF)

Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon‐alfa‐2a and ribavirin for chronic hepatitis C

Alimentary pharmacology & therapeutics, 2011-12, Vol.34 (11‐12), p.1306-1317

2011

Volltextzugriff (PDF)

Ciprofloxacin penetration into infected hepatic cysts in autosomal dominant polycystic kidney disease: a case report

Journal of antimicrobial chemotherapy, 2019-03, Vol.74 (3), p.829-830

2019

Volltextzugriff (PDF)

Biochemical Effects on the Liver of 1 Month of Alcohol Abstinence in Moderate Alcohol Consumers

Alcohol and alcoholism (Oxford), 2018-07, Vol.53 (4), p.435-438

2018

Volltextzugriff (PDF)

Inulin significantly improves serum magnesium levels in proton pump inhibitor‐induced hypomagnesaemia

Alimentary pharmacology & therapeutics, 2016-06, Vol.43 (11), p.1178-1185

2016

Volltextzugriff (PDF)

Treatment of hepatitis E infection in immuno-incompetent patients: reduction of immunosuppression appears to be more effective than ribavirin therapy

Journal of hepatology, 2017, Vol.66 (1), p.S331-S331

2017

Volltextzugriff (PDF)

Mental tests and cultural adaptation

Conference held in Istanbul, Turkey on July 19-23, 2018

Volltextzugriff (PDF)

Systematic review: periprocedural hydration in the prevention of post‐ERCP pancreatitis

Alimentary pharmacology & therapeutics, 2016-09, Vol.44 (6), p.541-553

2016

Volltextzugriff (PDF)

Daclatasvir 30 mg/day is the correct dose for patients taking atazanavir/cobicistat

Journal of antimicrobial chemotherapy, 2017-02, Vol.72 (2), p.486-489

2017

Volltextzugriff (PDF)

1 – 25 von 1.451

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.055)
Mit Volltextzugriff
(1.138)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(749)
Life Sciences & Biomedicine
(624)
Humans
(522)
Female
(295)
Male
(291)
Middle Aged
(224)
Adult
(216)
Biological And Medical Sciences
(211)
Gastroenterology & Hepatology
(186)
Medical Sciences
(144)
Aged
(123)
Physical Sciences
(101)
Chemistry
(87)
General & Internal Medicine
(80)
Medicine, General & Internal
(75)
Treatment Outcome
(74)
Adolescent
(73)
Animals
(72)
Fundamental And Applied Biological Sciences. Psychology
(70)
Risk Factors
(67)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Systematic review: hypomagnesaemia induced by proton pump inhibition

On-demand anakinra treatment is effective in mevalonate kinase deficiency

A Risk Assessment of Factors for the Presence of Angiodysplasias During Endoscopy and Factors Contributing to Symptomatic Bleeding and Rebleeds

Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation

The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes

NaV1.7 Gain-of-Function Mutations as a Continuum: A1632E Displays Physiological Changes Associated with Erythromelalgia and Paroxysmal Extreme Pain Disorder Mutations and Produces Symptoms of Both Disorders

Genetics and mechanisms of hepatic cystogenesis

Antiviral therapy in chronic hepatitis E: a systematic review

The long-term outcome of patients with polycystic liver disease treated with lanreotide

Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD study

Prospective multicentre cohort study of patient-reported outcomes after cholecystectomy for uncomplicated symptomatic cholecystolithiasis

Decreased tacrolimus plasma concentrations during HCV therapy: a drug–drug interaction or is there an alternative explanation?

Nav1.7-related small fiber neuropathy: impaired slow-inactivation and DRG neuron hyperexcitability

Somatostatin analogues improve health‐related quality of life in polycystic liver disease: a pooled analysis of two randomised, placebo‐controlled trials

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Safety and efficacy of different lanreotide doses in the treatment of polycystic liver disease: pooled analysis of individual patient data

Systematic review: the management of hepatic cyst infection

Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon‐alfa‐2a and ribavirin for chronic hepatitis C

Ciprofloxacin penetration into infected hepatic cysts in autosomal dominant polycystic kidney disease: a case report

Biochemical Effects on the Liver of 1 Month of Alcohol Abstinence in Moderate Alcohol Consumers

Inulin significantly improves serum magnesium levels in proton pump inhibitor‐induced hypomagnesaemia

Treatment of hepatitis E infection in immuno-incompetent patients: reduction of immunosuppression appears to be more effective than ribavirin therapy

Mental tests and cultural adaptation

Systematic review: periprocedural hydration in the prevention of post‐ERCP pancreatitis

Daclatasvir 30 mg/day is the correct dose for patients taking atazanavir/cobicistat

Suchergebnisse filtern